Oberwil, Switzerland

Oswald Schier


Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1977-1981

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Oswald Schier

Introduction

Oswald Schier is a noted inventor located in Oberwil, Switzerland, recognized for his significant contributions to pharmaceutical chemistry. With three patents to his name, Schier's inventions focus on developing compounds that serve as antihypertensive, antiarrhythmic, and antidepressant agents. His work plays a vital role in advancing medical treatments, showcasing the intersection of innovation and healthcare.

Latest Patents

Oswald Schier's latest patents include intricate chemical formulations that demonstrate his expertise in pharmacology. One of his significant inventions is related to piperidine derivatives, which are designed as antihypertensive and antiarrhythmic agents. This invention introduces piperidines defined by complex molecular structures, where variables such as R1, R2, and others indicate various chemical groups that contribute to their therapeutic properties.

Another noteworthy patent includes new phenylazacycloalkanes, particularly new 4-(phenyl)-piperidine compounds. These compounds are recognized for their potential use as antidepressant agents. The formula includes variations in substitutions around p-phenylene groups which amplify the efficacy of these compounds in clinical settings, marking a notable advancement in the field of mental health.

Career Highlights

Oswald Schier's career is highlighted by his pivotal role at Ciba-Geigy Corporation, a global leader in healthcare innovation (note: it may be referred to as Novartis today following a merger). During his time at Ciba-Geigy, he developed critical patentable ideas and worked on pharmaceutical solutions that have the potential to significantly impact patient care.

Collaborations

Throughout his career, Schier has collaborated with talented colleagues, including Kurt Eichenberger and Christian Egli. These collaborations have been instrumental in fostering innovative ideas and furthering research in medicinal chemistry. Together, they have contributed to a collaborative environment aimed at tackling complex health challenges through innovative solutions.

Conclusion

In conclusion, Oswald Schier stands out as an influential inventor within the pharmaceutical industry. His work not only showcases his inventive spirit but also highlights how impactful inventions can lead to advancements in medical science. With continued innovation, Schier’s contributions will surely resonate in the corridors of healthcare for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…